We are live on ! Find out more
FIM

Fernwood Investment Management Portfolio holdings

AUM $288M
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+26.86%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$202M
AUM Growth
+$45.7M
Cap. Flow
+$7.94M
Cap. Flow %
3.93%
Top 10 Hldgs %
28.77%
Holding
174
New
28
Increased
56
Reduced
50
Closed
8

Top Buys

Rank Stock Value
1
BBIO icon
BridgeBio Pharma
BBIO
+$1.27M
2
SNX icon
TD Synnex
SNX
+$1.14M
3
XLRN
Acceleron Pharma
XLRN
+$1.05M
4
ARCC icon
Ares Capital
ARCC
+$927K
5
IRM icon
Iron Mountain
IRM
+$873K

Top Sells

Rank Stock Value
1
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$2.61M
2
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$2.32M
3
CY
Cypress Semiconductor
CY
+$637K
4
GBT
Global Blood Therapeutics, Inc.
GBT
+$585K
5
DAY
Dayforce
DAY
+$581K

Sector Composition

Rank Sector Weight
1 Healthcare 23.66%
2 Technology 13.2%
3 Consumer Discretionary 7.8%
4 Financials 6.8%
5 Communication Services 6.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PM icon
26
Philip Morris
PM
$290B
$2.22M 1.1%
31,628
+530
+2% +$38.6K
IWM icon
27
iShares Russell 2000 ETF
IWM
$81.8B
$2.17M 1.07%
15,150
-149
-1% -$19.6K
IJH icon
28
iShares Core S&P Mid-Cap ETF
IJH
$127B
$2.15M 1.06%
60,455
-775
-1% -$25.7K
YUMC icon
29
Yum China
YUMC
$16.3B
$2.03M 1%
42,200
-700
-2% -$33K
MDT icon
30
Medtronic
MDT
$116B
$1.86M 0.92%
20,321
+89
+0.4% +$8.53K
BIIB icon
31
Biogen
BIIB
$30.1B
$1.81M 0.89%
6,760
– –
GOOG icon
32
Alphabet (Google) Class C
GOOG
$4.19T
$1.81M 0.89%
25,600
+400
+2% +$27K
LLY icon
33
Eli Lilly
LLY
$1.08T
$1.76M 0.87%
10,718
+70
+0.7% +$10.7K
DVY icon
34
iShares Select Dividend ETF
DVY
$23.7B
$1.68M 0.83%
20,821
-6,268
-23% -$501K
COUP
35
DELISTED
Coupa Software Incorporated
COUP
$1.65M 0.81%
5,950
-200
-3% -$40.3K
EMLP icon
36
First Trust North American Energy Infrastructure Fund
EMLP
$4.12B
$1.56M 0.77%
78,020
-1,860
-2% -$37.5K
AXON
37
Axon Enterprise
AXON
$51.7B
$1.55M 0.76%
15,750
-1,500
-9% -$121K
IRM icon
38
Iron Mountain
IRM
$36.4B
$1.54M 0.76%
59,150
+34,555
+140% +$873K
OLED icon
39
Universal Display
OLED
$4.32B
$1.53M 0.76%
10,215
+500
+5% +$73.4K
SWKS icon
40
Skyworks Solutions
SWKS
$10.3B
$1.52M 0.75%
11,925
-330
-3% -$36.6K
SNX icon
41
TD Synnex
SNX
$20.3B
$1.46M 0.72%
+24,430
New +$1.14M
MRVL icon
42
Marvell Technology
MRVL
$191B
$1.39M 0.69%
39,660
+3,810
+11% +$112K
STZ icon
43
Constellation Brands
STZ
$22.9B
$1.38M 0.68%
7,876
+1
+0% +$167
MSFT icon
44
Microsoft
MSFT
$3.74T
$1.38M 0.68%
6,765
+100
+2% +$18.2K
PSX icon
45
Phillips 66
PSX
$89.5B
$1.37M 0.68%
19,059
+425
+2% +$30.1K
ILMN icon
46
Illumina
ILMN
$29.1B
$1.36M 0.67%
3,778
– –
BRK.A icon
47
Berkshire Hathaway Class A
BRK.A
$1.11T
$1.34M 0.66%
5
-1
-17% -$274K
ABBV icon
48
AbbVie
ABBV
$442B
$1.33M 0.66%
13,595
+200
+1% +$17.6K
XLRN
49
DELISTED
Acceleron Pharma
XLRN
$1.32M 0.65%
13,900
+10,900
+363% +$1.05M
COR icon
50
Cencora
COR
$63.7B
$1.32M 0.65%
13,100
– –
1
2
3 4 5

Similar funds

CIM
Chiron Investment Management New York $300M AUM 49.09% 1-Year Est. Return
CSWM
Cassady Schiller Wealth Management Cincinnati, Ohio $273M AUM 17.91% 1-Year Est. Return
WWP
WR Wealth Planners Columbia, Missouri $311M AUM 18.22% 1-Year Est. Return
GWM
Gray Wealth Management Bangor, Maine $264M AUM 19.5% 1-Year Est. Return
FWM
Fairhaven Wealth Management Oak Brook, Illinois $320M AUM 17.7% 1-Year Est. Return
MWS
Maxwell Wealth Strategies Pleasanton, California $245M AUM 23.39% 1-Year Est. Return
AP
Agilis Partners Waltham, Massachusetts $332M AUM 10.57% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Fernwood Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Fernwood Investment Management held 174 positions worth $202M, up 29% from $157M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Fernwood Investment Management deployed $7.94M of net new capital in Q2 2020, opening 28 new positions and adding to 56 existing holdings. Its largest new stake was TD Synnex: 24,430 shares worth $1.46M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was MyoKardia, Inc. Common Stock, an estimated $2.61M trimmed.

  • Fernwood Investment Management's largest Q2 2020 buy was TD Synnex: 24,430 shares worth $1.46M.
  • Fernwood Investment Management added most to BridgeBio Pharma in Q2 2020, an estimated $1.27M increase.
  • Fernwood Investment Management's biggest Q2 2020 reduction was MyoKardia, Inc. Common Stock, cutting an estimated $2.61M.
  • Fernwood Investment Management fully exited Portola Pharmaceuticals, Inc. in Q2 2020, selling an estimated $2.32M.
  • Fernwood Investment Management's ten largest holdings make up 29% of its $202M portfolio in Q2 2020.
  • Fernwood Investment Management opened 28 new positions and closed 8 in Q2 2020.
  • Fernwood Investment Management's portfolio value rose 29% quarter-over-quarter to $202M.

Based on Fernwood Investment Management's 13F filing for Q2 2020, filed 6 Aug 2020.